Grossman A, Savage M O, Wass J A, Lytras N, Sueiras-Diaz J, Coy D H, Besser G M
Lancet. 1983 Jul 16;2(8342):137-8. doi: 10.1016/s0140-6736(83)90118-6.
Four patients with hypothalamic tumours or idiopathic growth hormone (GH) deficiency, who were GH deficient by conventional criteria, responded to 200 micrograms synthetic hpGRF-40 with a clear rise in circulating GH.
4例患有下丘脑肿瘤或特发性生长激素(GH)缺乏症的患者,按照传统标准属于GH缺乏,对200微克合成的hpGRF-40有反应,循环中的GH明显升高。